$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023239 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.300M	$1.186M
YoY Change	-4.41%	3.49%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.300M	$1.186M
YoY Change	-4.41%	3.49%
Operating Profit	-$1.313M	-$1.186M
YoY Change	-3.46%	3.49%
Interest Expense	$600.0K	-$1.510M
YoY Change	-175.76%	-194.43%
% of Operating Profit
Other Income/Expense, Net	$1.661M	-$166.0K
YoY Change	-264.13%	-653.33%
Pretax Income	$932.0K	-$2.862M
YoY Change	-129.46%	-692.55%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$932.0K	-$2.862M
YoY Change	-129.46%	-692.55%
Net Earnings / Revenue
Basic Earnings Per Share	$0.06	-$0.18
Diluted Earnings Per Share	$0.06	-$0.18
COMMON SHARES
Basic Shares Outstanding	16.52M	16.31M
Diluted Shares Outstanding	16.29K	16.14K

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.70M	$15.00M
YoY Change	-25.19%	-14.33%
Cash & Equivalents	$15.70M	$14.20M
Short-Term Investments	$0.00	$800.0K
Other Short-Term Assets	$600.0K	$1.640M
YoY Change	-78.78%	-53.91%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.28M	$16.73M
YoY Change	-31.65%	-20.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.100M	$1.136M
YoY Change	-19.24%	-20.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.68M	$10.43M
YoY Change	-13.36%	-44.69%
Other Assets	$255.0K	$247.0K
YoY Change	-25.87%	-7.49%
Total Long-Term Assets	$16.15M	$14.36M
YoY Change	-17.51%	-42.33%
TOTAL ASSETS
Total Short-Term Assets	$16.28M	$16.73M
Total Long-Term Assets	$16.15M	$14.36M
Total Assets	$32.43M	$31.08M
YoY Change	-25.27%	-32.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$103.0K	$67.00K
YoY Change	1044.44%	19.64%
Accrued Expenses	$782.0K	$567.0K
YoY Change	-24.37%	9.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.563M	$1.256M
YoY Change	-16.46%	9.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$50.00K	$50.00K
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$50.00K	$50.00K
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.563M	$1.256M
Total Long-Term Liabilities	$50.00K	$50.00K
Total Liabilities	$2.501M	$2.319M
YoY Change	-23.82%	-12.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$729.3M	-$730.2M
YoY Change	1.43%	2.01%
Common Stock	$803.3M	$803.5M
YoY Change	-0.44%	-0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.90M	$28.76M
YoY Change
Total Liabilities & Shareholders Equity	$32.43M	$31.08M
YoY Change	-25.27%	-32.37%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$932.0K	-$2.862M
YoY Change	-129.46%	-692.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$400.0K	-$1.133M
YoY Change	-28.7%	3.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.900M	$4.397M
YoY Change	-222.74%	2251.34%
Cash From Investing Activities	$1.900M	$4.397M
YoY Change	-222.74%	2251.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-26.00K
YoY Change	-72.83%	-97.36%
NET CHANGE
Cash From Operating Activities	-400.0K	-1.133M
Cash From Investing Activities	1.900M	4.397M
Cash From Financing Activities	-100.0K	-26.00K
Net Change In Cash	1.400M	3.238M
YoY Change	-156.52%	-270.69%
FREE CASH FLOW
Cash From Operating Activities	-$400.0K	-$1.133M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21573000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21573000
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5098000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5478000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
CY2023Q2	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
CY2022Q2	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-5620
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-1609753
	dei	Entity Address Address Line1 EntityAddressAddressLine1	150 N. Radnor Chester Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Radnor
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19087
	dei	City Area Code CityAreaCode	610
	dei	Local Phone Number LocalPhoneNumber	293-0600
	dei	Security12b Title Security12bTitle	common stock, par value $0.10
	dei	Trading Symbol TradingSymbol	SFE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16521070
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14246000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13331000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	841000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5956000	usd
CY2023Q2	us-gaap	Trading Securities TradingSecurities	0	usd
CY2022Q4	us-gaap	Trading Securities TradingSecurities	860000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1615000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1251000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	16727000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21423000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1136000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1290000	usd
CY2023Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	12972000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	14545000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	247000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	434000	usd
CY2023Q2	us-gaap	Assets Assets	31082000	usd
CY2022Q4	us-gaap	Assets Assets	37692000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	67000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	164000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	507000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	567000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	865000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	458000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	429000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1256000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1817000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1013000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1249000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2319000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3116000	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	801312000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	804752000	usd
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	44437000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	48410000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-730244000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-723898000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28763000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31082000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37692000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1146000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2371000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2380000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1186000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1146000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2371000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2380000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-166000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-175000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1967000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	249000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	145000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	523000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	246000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1759000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1454000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4323000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2125000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2862000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	483000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6346000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6226000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2862000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
	us-gaap	Profit Loss ProfitLoss	-6346000	usd
	us-gaap	Profit Loss ProfitLoss	-6226000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16143
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16356
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16108
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16468
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16143
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16356
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16108
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16468
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2061000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2099000	usd
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	1287000	usd
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	485000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3000000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	-0	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	250000	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	3400000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8530000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	13800000	usd
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3307000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2915000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	75000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1723000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	256000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	492000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-331000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2215000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	915000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7229000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24764000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14271000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17535000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3484000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	75000	usd
CY2023Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-207000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	168000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31392000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2862000	usd
CY2023Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-60000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28763000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50566000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-6709000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	779000	usd
CY2022Q1	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-303000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	168000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43549000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	945000	usd
CY2022Q2	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-65000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	143000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43295000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14200000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	800000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	10428000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8846000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1144000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2177000	usd
CY2023Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	1400000	usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	4382000	usd
CY2023Q2	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	12972000	usd
CY2022Q4	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	15405000	usd
	sfe	Impairment Of Other Method Securities ImpairmentOfOtherMethodSecurities	200000	usd
	sfe	Impairment Of Other Method Securities ImpairmentOfOtherMethodSecurities	0	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	278000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	262000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	570000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	576000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2862000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
	us-gaap	Profit Loss ProfitLoss	-6346000	usd
	us-gaap	Profit Loss ProfitLoss	-6226000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16143
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16356
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16108
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16468
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2862000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
	us-gaap	Profit Loss ProfitLoss	-6346000	usd
	us-gaap	Profit Loss ProfitLoss	-6226000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16143
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16356
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16108
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16468
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	0
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16143
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16356
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16108
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16468
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	304000	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Remainder Of Fiscal Year LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear	281000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	613000	usd
CY2023Q2	sfe	Lessee Sublease Expected Receipts Year One LesseeSubleaseExpectedReceiptsYearOne	573000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	619000	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Year Two LesseeSubleaseexpectedReceiptsYearTwo	590000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	207000	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Year Three LesseeSubleaseexpectedReceiptsYearThree	199000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Year Four LesseeSubleaseexpectedReceiptsYearFour	0	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	0	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Year Five LesseeSubleaseexpectedReceiptsYearFive	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q2	sfe	Lessee Subleaseexpected Receipts Thereafter LesseeSubleaseexpectedReceiptsThereafter	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1743000	usd
CY2023Q2	sfe	Lessee Sublease Expected Receipts Total LesseeSubleaseExpectedReceiptsTotal	1643000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	273000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1470000	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	0	usd
CY2023Q2	sfe	Employee And Severance Agreement Maximum Aggregate Exposure EmployeeAndSeveranceAgreementMaximumAggregateExposure	1000000.0	usd
	sfe	Employee And Severance Agreement Maximum Aggregate Exposure Shares EmployeeAndSeveranceAgreementMaximumAggregateExposureShares	187500

Files In Submission

Name	View Source	Status
0001437749-23-023239-index-headers.html	Edgar Link	pending
0001437749-23-023239-index.html	Edgar Link	pending
0001437749-23-023239.txt	Edgar Link	pending
0001437749-23-023239-xbrl.zip	Edgar Link	pending
ex_525434.htm	Edgar Link	pending
ex_525435.htm	Edgar Link	pending
ex_525436.htm	Edgar Link	pending
ex_525437.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20230630.xsd	Edgar Link	pending
sfe20230630_10q.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sfe-20230630_lab.xml	Edgar Link	unprocessable
sfe-20230630_pre.xml	Edgar Link	unprocessable
sfe20230630_10q_htm.xml	Edgar Link	completed
sfe-20230630_cal.xml	Edgar Link	unprocessable
sfe-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2023 Q3 Form 10-Q Financial Statement

#000143774923023239 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2023 Q3 Form 10-Q Financial Statement

#000143774923023239 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes